Regulus Therapeutics

Regulus Therapeutics

Regulus Therapeutics Careers, Pay and Expert Network

lightbulbWhat are the highest paying jobs at Regulus Therapeutics?

Regulus Therapeutics Inc. or Regulus is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.

Snapshot

Employees21
IndustryBiotech
Market Cap$15.4 million
Revenue$100,000
5 Year Trend-67.4%
Net Income-$48.7 million
NASDRGLS
Founded2007
Annual Report
stats icon
% Masters:
20%